Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CD22 | P20273 | 8/20 | 0.45 |
| ▸ | MAG | P20916 | 3/20 | 0.45 |
| ▸ | SELL | P14151 | 1/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.44 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL358286 | 0.95 | NANP (0.56) | NANPL3MBTL1CD22MAGSELL | |
| SCHEMBL593858 | 0.90 | NANP (0.52) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL1073940 | 0.90 | NANP (0.52) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL9479903 | 0.89 | NANP (0.51) | NANPL3MBTL1CD22MAGSELL | |
| SCHEMBL343246 | 0.89 | NANP (0.51) | NANPL3MBTL1CD22MAGSELL | |
| SCHEMBL9697921 | 0.88 | NANP (0.59) | NANPL3MBTL1CD22MAGSELL | |
| SCHEMBL10699657 | 0.86 | NANP (0.52) | NANPL3MBTL1CD22MAG | |
| SCHEMBL3493295 | 0.85 | NANP (0.47) | NANPL3MBTL1MAGSELLSELP | |
| SCHEMBL442944 | 0.84 | NANP (0.61) | NANPL3MBTL1CD22MAGSELL | |
| SCHEMBL8664558 | 0.84 | NANP (0.64) | NANPL3MBTL1CD22MAGSELL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538544-B1 | SUBTILASE CYTOTOXIN B SUBUNIT MUTANT | UNIV GRIFFITH (AU) | 2024-03-27 | — | — | EP | disclosed |
| US-20240084322-A1 | CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE | JPMORGAN CHASE BANK, N.A. | 2024-03-14 | — | — | US | disclosed |
| CN-110913903-B | Glycan interaction compounds and methods of use | 思进股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-20240009306-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2024-01-11 | — | — | US | disclosed |
| US-20240002537-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20240002422-A1 | Glycan Analysis and Profiling | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20240000962-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| US-20240003889-A1 | Compositions and Methods for Targeting Cancer Stem Cells | SEAGEN INC. (US) | 2024-01-04 | — | — | US | disclosed |
| CN-117157406-A | Cells, tissues, organs and animals having one or more modified genes for enhancing xenograft survival and tolerance | E开创生物技术股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20230331868-A1 | Glycan-Interacting Compounds and Methods of Use | SEAGEN INC. (US) | 2023-10-19 | — | — | US | disclosed |
| WO-2007022799-A1 | PROCESS FOR THE PREPARATION OF GLYCOSYLATED INTERFERON BETA | ARES TRADING S.A. (CH) | 2007-03-01 | — | — | WO | disclosed |
| EP-1747289-A1 | OLIGONUCLEOTIDE ARRAYS TO MONITOR GENE EXPRESSION AND METHODS FOR MAKING AND USING SAME | Wyeth (US) | 2007-01-31 | — | — | EP | disclosed |
| EP-1747294-A2 | NOVEL POLYNUCLEOTIDES RELATED TO OLIGONUCLEOTIDE ARRAYS TO MONITOR GENE EXPRESSION | Wyeth a Corporation of the State of Delaware (US) | 2007-01-31 | — | — | EP | disclosed |
| WO-2007006864-A2 | METHOD FOR EVALUATING CELL POPULATIONS | SUOMEN PUNAINEN RISTI, VERIPALVELU (FI) | 2007-01-18 | — | — | WO | disclosed |
| EP-1651955-A2 | METHODS FOR DETECTING AND ANALYZING N-GLYCOLYLNEURAMINIC ACID (NEU5GC) IN BIOLOGICAL MATERIALS | The Regents of The University of California (US) | 2006-05-03 | — | — | EP | disclosed |
| WO-2006025879-A2 | NOVEL POLYNUCLEOTIDES RELATED TO OLIGONUCLEOTIDE ARRAYS TO MONITOR GENE EXPRESSION | WYETH (US) | 2006-03-09 | — | — | WO | disclosed |
| US-20060010513-A1 | Oligonucleotide arrays to monitor gene expression and methods for making and using same | WYETH | 2006-01-12 | — | — | US | disclosed |
| US-20060003958-A1 | Novel polynucleotides related to oligonucleotide arrays to monitor gene expression | WYETH | 2006-01-05 | — | — | US | disclosed |
| WO-2005111246-A1 | OLIGONUCLEOTIDE ARRAYS TO MONITOR GENE EXPRESSION AND METHODS FOR MAKING AND USING SAME | WYETH (US) | 2005-11-24 | — | — | WO | disclosed |
| WO-2005010485-A2 | METHODS FOR DETECTING AND ANALYZING N-GLYCOLYLNEURAMINIC ACID (NEU5GC) IN BIOLOGICAL MATERIALS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-02-03 | — | — | WO | disclosed |